These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18314458)

  • 1. Effects of ubiquitin-proteasome system deregulation on the vascular senescence and atherosclerosis process in elderly patients.
    Marfella R; Di Filippo C; Laieta MT; Vestini R; Barbieri M; Sangiulo P; Crescenzi B; Ferraraccio F; Rossi F; D'Amico M; Paolisso G
    J Gerontol A Biol Sci Med Sci; 2008 Feb; 63(2):200-3. PubMed ID: 18314458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment.
    Marfella R; D'Amico M; Esposito K; Baldi A; Di Filippo C; Siniscalchi M; Sasso FC; Portoghese M; Cirillo F; Cacciapuoti F; Carbonara O; Crescenzi B; Baldi F; Ceriello A; Nicoletti GF; D'Andrea F; Verza M; Coppola L; Rossi F; Giugliano D
    Diabetes; 2006 Mar; 55(3):622-32. PubMed ID: 16505224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment.
    Marfella R; D'Amico M; Di Filippo C; Baldi A; Siniscalchi M; Sasso FC; Portoghese M; Carbonara O; Crescenzi B; Sangiuolo P; Nicoletti GF; Rossiello R; Ferraraccio F; Cacciapuoti F; Verza M; Coppola L; Rossi F; Paolisso G
    J Am Coll Cardiol; 2006 Jun; 47(12):2444-55. PubMed ID: 16781372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: role of ubiquitin-proteasome activity.
    Marfella R; Siniscalchi M; Portoghese M; Di Filippo C; Ferraraccio F; Schiattarella C; Crescenzi B; Sangiuolo P; Ferraro G; Siciliano S; Cinone F; Mazzarella G; Martis S; Verza M; Coppola L; Rossi F; D'Amico M; Paolisso G
    Hypertension; 2007 Apr; 49(4):784-91. PubMed ID: 17309948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome activity as a target of hormone replacement therapy-dependent plaque stabilization in postmenopausal women.
    Marfella R; Di Filippo C; Portoghese M; Ferraraccio F; Crescenzi B; Siniscalchi M; Barbieri M; Bologna C; Rizzo MR; Rossi F; D'Amico M; Paolisso G
    Hypertension; 2008 Apr; 51(4):1135-41. PubMed ID: 18259030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the ubiquitin-proteasome system in carotid plaque instability in diabetic patients.
    Marfella R; Cacciapuoti F; Grassia A; Manfredi E; De Maio G; Caruso G; Pepe M; Nittolo G; Cacciapuoti F
    Acta Cardiol; 2006 Dec; 61(6):630-6. PubMed ID: 17205920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of the ubiquitin-proteasome system in human carotid atherosclerosis.
    Versari D; Herrmann J; Gössl M; Mannheim D; Sattler K; Meyer FB; Lerman LO; Lerman A
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2132-9. PubMed ID: 16778122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized LDL in human carotid plaques is related to symptomatic carotid disease and lesion instability.
    Sigala F; Kotsinas A; Savari P; Filis K; Markantonis S; Iliodromitis EK; Gorgoulis VG; Andreadou I
    J Vasc Surg; 2010 Sep; 52(3):704-13. PubMed ID: 20573470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of ubiquitin and 26S proteasome in human obesity.
    Chang TL; Chang CJ; Lee WY; Lin MN; Huang YW; Fan K
    Metabolism; 2009 Nov; 58(11):1643-8. PubMed ID: 19616267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes, ubiquitin proteasome system and atherosclerotic plaque rupture.
    Marfella R; Di Filippo C; D'Amico M; Paolisso G
    Circ Res; 2007 May; 100(10):e84-5. PubMed ID: 17525372
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeting the ubiquitin-proteasome system in atherosclerosis: status quo, challenges, and perspectives.
    Wilck N; Ludwig A
    Antioxid Redox Signal; 2014 Dec; 21(17):2344-63. PubMed ID: 24506455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic fibroblast growth factor mediates carotid plaque instability through metalloproteinase-2 and -9 expression.
    Sapienza P; di Marzo L; Borrelli V; Sterpetti AV; Mingoli A; Piagnerelli R; Cavallaro A
    Eur J Vasc Endovasc Surg; 2004 Jul; 28(1):89-97. PubMed ID: 15177237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of ubiquitin-proteasome system, caspase enzyme activities, and extracellular proteinases in rat soleus muscle in response to unloading.
    Berthon P; Duguez S; Favier FB; Amirouche A; Feasson L; Vico L; Denis C; Freyssenet D
    Pflugers Arch; 2007 Jul; 454(4):625-33. PubMed ID: 17334780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular unloading is associated with increased 20s proteasome protein expression in the myocardium.
    Wohlschlaeger J; Sixt SU; Stoeppler T; Schmitz KJ; Levkau B; Tsagakis K; Vahlhaus C; Schmid C; Peters J; Schmid KW; Milting H; Baba HA
    J Heart Lung Transplant; 2010 Jan; 29(1):125-32. PubMed ID: 19837610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between 5-lipoxygenase expression and plaque instability in humans.
    Cipollone F; Mezzetti A; Fazia ML; Cuccurullo C; Iezzi A; Ucchino S; Spigonardo F; Bucci M; Cuccurullo F; Prescott SM; Stafforini DM
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1665-70. PubMed ID: 15933245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding expression of the 5-lipoxygenase/leukotriene B4 pathway in atherosclerotic lesions of diabetic patients promotes plaque instability.
    Zhou YJ; Wang JH; Li L; Yang HW; Wen de L; He QC
    Biochem Biophys Res Commun; 2007 Nov; 363(1):30-6. PubMed ID: 17825794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidism.
    Marfella R; Ferraraccio F; Rizzo MR; Portoghese M; Barbieri M; Basilio C; Nersita R; Siniscalchi LI; Sasso FC; Ambrosino I; Siniscalchi M; Maresca L; Sardu C; Amato G; Paolisso G; Carella C
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1015-20. PubMed ID: 21239513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy.
    Birks EJ; Latif N; Enesa K; Folkvang T; Luong le A; Sarathchandra P; Khan M; Ovaa H; Terracciano CM; Barton PJ; Yacoub MH; Evans PC
    Cardiovasc Res; 2008 Aug; 79(3):472-80. PubMed ID: 18375498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible dual role of ubiquitin-proteasome system in the atherosclerotic plaque progression.
    Di Filippo C; Marfella R; D'Amico M
    J Am Coll Cardiol; 2008 Oct; 52(16):1350-1; author reply 1351. PubMed ID: 18929250
    [No Abstract]   [Full Text] [Related]  

  • 20. Integrated analysis of microarray data of atherosclerotic plaques: modulation of the ubiquitin-proteasome system.
    Wang Z; Guo D; Yang B; Wang J; Wang R; Wang X; Zhang Q
    PLoS One; 2014; 9(10):e110288. PubMed ID: 25333956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.